Friday, May 22, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

Business of Denying Medical Care

Profit over patients

Jay K Joshi by Jay K Joshi
May 11, 2024
in Financial Markets
0
Business of Denying Medical Care

Getty Images

Insurance companies, like any other business, aim to maximize profits and minimize costs. One way they achieve this is by denying patients medical care. By denying or delaying coverage for certain treatments or procedures, insurance companies can save money on claims payouts and increase their bottom line.

One way insurance companies benefit from denying medical care is by reducing their overall expenses. Medical treatments and procedures can be costly, and by denying coverage for certain services or treatments, insurance companies can save a significant amount of money. This not only benefits the insurance company financially but also helps keep premiums lower for all policyholders.

Another way insurance companies benefit from denying medical care is by controlling healthcare costs for conditions and treatments covered. By limiting coverage for certain treatments or procedures, insurance companies can keep their overall costs down and avoid paying for unnecessary or overly expensive services. This helps them remain competitive in the market and attract more customers.

The metric used by insurance companies is as clear as it is callous to patient care. PMPM, which stands for Per Member Per Month, is a common metric used by health insurance companies to allocate coverage and control costs. This metric calculates the average cost of providing healthcare services to each individual covered by the insurance plan on a monthly basis.By analyzing the PMPM metric, insurance companies can evaluate the overall cost of healthcare services for their members and make strategic decisions to manage these costs effectively. This includes determining appropriate premium rates, setting coverage limits, negotiating with healthcare providers for better rates, and implementing cost containment measures.

One of the key benefits of using the PMPM metric is that it allows insurance companies to assess the financial impact of various healthcare services and procedures. This information helps them identify cost drivers, monitor trends in healthcare utilization, and develop strategies to mitigate rising costs.

Additionally, the PMPM metric can also be used to evaluate the effectiveness of various healthcare programs and initiatives aimed at improving member health outcomes. By tracking the cost of providing care per member per month, insurance companies can assess the return on investment of these programs and make informed decisions on future investments. By analyzing this metric, insurance companies can make data-driven decisions that benefit both their bottom line and the health and well-being of their members. It is the means by which they justify denying medical care to patients.

Denying medical care allows insurance companies to manage their risks effectively. By only approving essential treatments and procedures, they can better predict their future expenses and mitigate potential losses. This risk management strategy ensures the long-term stability and profitability of the insurance company. Moreover, denying unnecessary medical care also helps prevent healthcare fraud and abuse, protecting the company and its policyholders from fraudulent claims and inflated costs. Overall, while denying medical care may seem unethical from a patient’s perspective, it is a necessary practice for insurance companies to stay financially viable and provide affordable coverage to their customers.

Insurance companies benefit from denying patients medical care by reducing expenses, controlling healthcare costs, and managing their risk. While this may seem like a negative practice, it is ultimately a strategy to ensure the sustainability and profitability of the insurance company. It is important for patients to be aware of their rights and options when it comes to challenging denial of coverage and advocating for their healthcare needs.

Health insurance denials can be frustrating and overwhelming for patients who require medically necessary coverage for their treatment. However, patients do have options to challenge these denials and fight for the coverage they need. It is important for patients to be proactive and informed when facing a denial from their health insurance provider.

The first step for patients facing a denial is to review their health insurance policy carefully. Obtain a copy and read it thoroughly. Understanding the terms and conditions of their policy can help patients determine if the denial is legitimate or if it goes against their coverage. Patients should also review the denial letter from their insurance provider to understand the reason for the denial and the specific details of the decision.

Once patients have a clear understanding of the denial, they can begin the process of appealing the decision. Most health insurance companies have an appeal process in place for patients to challenge denials. Patients should follow the instructions outlined in the denial letter on how to submit an appeal, which typically involves providing additional information or documentation to support the medical necessity of the treatment.

Patients can also seek assistance from their healthcare provider in appealing the denial. Healthcare providers can provide medical records, documentation, and support letters to support the patient’s case and demonstrate the medical necessity of the treatment. Patients can also enlist the help of a patient advocate or legal support to navigate the appeals process and ensure that their rights are protected.

In some cases, patients may need to escalate their appeal to an external review board or seek support from a state agency that oversees health insurance regulations. Patients should explore all available options to challenge the denial and fight for the coverage they need for their medical treatment. This begins by learning specific consumer protections they enjoy.

Review this website to see how you can escalate a patient denial claim.

Overall, challenging health insurance denials requires patience, persistence, and advocacy on the part of the patient. By being informed, proactive, and seeking support from healthcare providers and advocates, patients can increase their chances of overturning denials and obtaining the medically necessary coverage they deserve.


We wrote a satire about this very situation, titled: A Patient Named Candide

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Joshi is the founding editor of Daily Remedy.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex

    The IRA’s Drug Negotiation Mechanism Meets the Rebate Industrial Complex

    0 shares
    Share 0 Tweet 0
  • One Dose, Many Decades

    0 shares
    Share 0 Tweet 0
  • The Price Is Right, Theoretically: What Turquoise Health Actually Reveals About Hospital Markets

    0 shares
    Share 0 Tweet 0
  • Two Platforms, Two Theories of Change in Hospital Pricing

    0 shares
    Share 0 Tweet 0
  • Will Drug Prices Actually Fall?

    0 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy